North America Rapid Acting Insulin Market

North America Rapid Acting Insulin Market By Product Type (Insulin Lispro, Insulin Aspart and Insulin Glulisine), By Indication (Type 2 Diabetes and Type 1 Diabetes), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Providers), By Country, Growth Potential, Industry Analysis Report and Forecast, 2021 - 2027

Report Id: KBV-5834 Publication Date: May-2021 Number of Pages: 79
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support
TABLE 1 North America Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 2 North America Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Rapid Acting Insulin Market]
TABLE 4 Product Launches And Product Expansions– Rapid Acting Insulin Market
TABLE 5 Acquisition and Mergers– Rapid Acting Insulin Market
TABLE 6 Approvals and Trials– Rapid Acting Insulin Market
TABLE 7 North America Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 8 North America Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 9 North America Insulin Lispro Market by Country, 2017 - 2020, USD Million
TABLE 10 North America Insulin Lispro Market by Country, 2021 - 2027, USD Million
TABLE 11 North America Insulin Aspart Market by Country, 2017 - 2020, USD Million
TABLE 12 North America Insulin Aspart Market by Country, 2021 - 2027, USD Million
TABLE 13 North America Insulin Glulisine Market by Country, 2017 - 2020, USD Million
TABLE 14 North America Insulin Glulisine Market by Country, 2021 - 2027, USD Million
TABLE 15 North America Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 16 North America Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 17 North America Type 2 Diabetes Market by Country, 2017 - 2020, USD Million
TABLE 18 North America Type 2 Diabetes Market by Country, 2021 - 2027, USD Million
TABLE 19 North America Type 1 Diabetes Market by Country, 2017 - 2020, USD Million
TABLE 20 North America Type 1 Diabetes Market by Country, 2021 - 2027, USD Million
TABLE 21 North America Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 22 North America Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 23 North America Hospital Pharmacies Market by Country, 2017 - 2020, USD Million
TABLE 24 North America Hospital Pharmacies Market by Country, 2021 - 2027, USD Million
TABLE 25 North America Drug Stores & Retail Pharmacies Market by Country, 2017 - 2020, USD Million
TABLE 26 North America Drug Stores & Retail Pharmacies Market by Country, 2021 - 2027, USD Million
TABLE 27 North America Online Providers Market by Country, 2017 - 2020, USD Million
TABLE 28 North America Online Providers Market by Country, 2021 - 2027, USD Million
TABLE 29 North America Rapid Acting Insulin Market by Country, 2017 - 2020, USD Million
TABLE 30 North America Rapid Acting Insulin Market by Country, 2021 - 2027, USD Million
TABLE 31 US Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 32 US Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 33 US Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 34 US Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 35 US Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 36 US Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 37 US Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 38 US Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 39 Canada Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 40 Canada Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 41 Canada Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 42 Canada Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 43 Canada Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 44 Canada Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 45 Canada Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 46 Canada Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 47 Mexico Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 48 Mexico Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 49 Mexico Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 50 Mexico Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 51 Mexico Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 52 Mexico Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 53 Mexico Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 54 Mexico Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 55 Rest of North America Rapid Acting Insulin Market, 2017 - 2020, USD Million
TABLE 56 Rest of North America Rapid Acting Insulin Market, 2021 - 2027, USD Million
TABLE 57 Rest of North America Rapid Acting Insulin Market by Product Type, 2017 - 2020, USD Million
TABLE 58 Rest of North America Rapid Acting Insulin Market by Product Type, 2021 - 2027, USD Million
TABLE 59 Rest of North America Rapid Acting Insulin Market by Indication, 2017 - 2020, USD Million
TABLE 60 Rest of North America Rapid Acting Insulin Market by Indication, 2021 - 2027, USD Million
TABLE 61 Rest of North America Rapid Acting Insulin Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 62 Rest of North America Rapid Acting Insulin Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 63 key information - Merck & Co., Inc.
TABLE 64 Key Information – Sanofi S.A.
TABLE 65 Key information – Novo Nordisk A/S
TABLE 66 Key Information – Eli Lilly and Company
TABLE 67 key information – Adocia SA
TABLE 68 Key Information – Biocon Limited
TABLE 69 Key Information – Gan & Lee Pharmaceuticals
TABLE 70 key Information – Geropharm LLC
TABLE 71 Key Information – Wockhardt Ltd.
TABLE 72 Key Information – MannKind Corporation

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2016-2020)
FIG 4 Recent strategies and developments: Novo Nordisk A/S
FIG 5 Recent strategies and developments: Eli Lilly and Company
FIG 6 Recent strategies and developments: MannKind Corporation
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo